Xenon Pharmaceuticals Inc. (XENE) — Dilution Risk Analysis

Current Snapshot

Xenon Pharmaceuticals Inc. (XENE) has a DilutionWatch score of 24/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
96,840,432 Source
Public Float
90,770,885 Source
Float as % of Outstanding
93.7%

Dilution Risk Score

Score: 24/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: XBRL 1, 4 6, 424B5 2, 8-K 1.

FormFiledAccession
xbrl 2026-06-30 xbrl-2440-xbrl_warrant
4 2026-03-13 0001193125-26-106724
4 2026-03-13 0001193125-26-106726
4 2026-03-13 0001193125-26-106727
424B5 2026-03-12 0001193125-26-102517
8-K 2026-03-12 0001193125-26-104199
4 2026-03-11 0001193125-26-102669
4 2026-03-11 0001193125-26-102666
4 2026-03-11 0001193125-26-102667
424B5 2026-03-09 0001193125-26-098764

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $400,000,000 Source
Cash runway 49 months Source
Three-year share count growth 48.01% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 24/10) Source
Cash Runway
49 months Source
ATM Offering Capacity Remaining
$400,000,000 Source
Share Count Growth (3-Year)
48.01% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.